Yoshitaka Iso

2.1k total citations
77 papers, 1.5k citations indexed

About

Yoshitaka Iso is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Yoshitaka Iso has authored 77 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 32 papers in Surgery and 23 papers in Molecular Biology. Recurrent topics in Yoshitaka Iso's work include Mesenchymal stem cell research (15 papers), Angiogenesis and VEGF in Cancer (14 papers) and Cardiovascular Function and Risk Factors (8 papers). Yoshitaka Iso is often cited by papers focused on Mesenchymal stem cell research (15 papers), Angiogenesis and VEGF in Cancer (14 papers) and Cardiovascular Function and Risk Factors (8 papers). Yoshitaka Iso collaborates with scholars based in Japan, United States and Panama. Yoshitaka Iso's co-authors include Hiroshi Suzuki, Shinji Koba, Takashi Katagiri, Jeffrey L. Spees, Burton E. Sobel, Claudia Serrano, Benjamin Bakondi, Yao‐Hua Song, Radhika Pochampally and Patrice Delafontaine and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Yoshitaka Iso

74 papers receiving 1.5k citations

Peers

Yoshitaka Iso

SURGE

GENET

CCM

EDM

Farhad Forudi United States

Cyrile Anne Curat Germany

Aaron M. Abarbanell United States

Toshifumi Shimada Japan

Paola Rizzo Italy

Takashi Omura Japan

Soichiro Fujiyama Japan

Constance J. Temm United States

Téni G. Ebrahimian France

Ryo Suzuki Japan

Farhad Forudi United States

Yoshitaka Iso

724 ×1.2

SURGE

800 ×1.7

548 ×1.3

GENET

544 ×1.6

CCM

140 ×0.6

EDM

Citations per year, relative to Yoshitaka Iso Yoshitaka Iso (= 1×) peers Farhad Forudi

Countries citing papers authored by Yoshitaka Iso

Since Specialization

Citations

This map shows the geographic impact of Yoshitaka Iso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshitaka Iso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshitaka Iso more than expected).

Fields of papers citing papers by Yoshitaka Iso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshitaka Iso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshitaka Iso. The network helps show where Yoshitaka Iso may publish in the future.

Co-authorship network of co-authors of Yoshitaka Iso

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshitaka Iso. A scholar is included among the top collaborators of Yoshitaka Iso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshitaka Iso. Yoshitaka Iso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Okada, Takahiro, et al.. (2025). Clinical Evaluation and Outcome in Heart Failure Patients Receiving Chemotherapy with Different Anti-Cancer Agents. ESC Heart Failure. 12(3). 1965–1976. 1 indexed citations

Iso, Yoshitaka, et al.. (2024). Is systolic blood pressure an early marker of concentric left ventricular geometry in young rugby athletes as a potential cardiac maladaptation?. International Journal of Cardiology Cardiovascular Risk and Prevention. 24. 200362–200362.

Nagumo, Sakura, et al.. (2024). Prognostic Value of Left Atrial Reverse Remodelling in Patients Hospitalized with Acute Decompensated Heart Failure. ESC Heart Failure. 11(6). 4285–4295. 2 indexed citations

Iso, Yoshitaka, et al.. (2023). Mesenchymal Stem/Stromal Cells in Skeletal Muscle Are Pro-Angiogenic, and the Effect Is Potentiated by Erythropoietin. Pharmaceutics. 15(4). 1049–1049. 4 indexed citations

Iso, Yoshitaka, Fumiyoshi Tsunoda, Naoya Nishinaka, et al.. (2019). Prevalence and significance of sleep disordered breathing in adolescent athletes. ERJ Open Research. 5(1). 29–2019. 8 indexed citations

Imai, Hideyuki, et al.. (2019). Factors involved in body weight loss and its maintenance in morbidly obese inpatients. Diabetology International. 11(1). 41–48. 4 indexed citations

Ochiai, Hiroko, Kazuo Kishi, Yoshiaki Kubota, et al.. (2017). Transplanted mesenchymal stem cells are effective for skin regeneration in acute cutaneous wounds of pigs. Regenerative Therapy. 7. 8–16. 20 indexed citations

Iso, Yoshitaka, et al.. (2016). The histological characteristics and virtual histology findings of the tissues obtained by a distal protection device during endovascular therapy for peripheral artery disease. Journal of Cardiology. 69(1). 125–130. 5 indexed citations

Shirai, Remina, Yui Takahashi, Miho Kojima, et al.. (2016). Facilitatory effects of fetuin-A on atherosclerosis. Atherosclerosis. 246. 344–351. 58 indexed citations

10.

Iso, Yoshitaka, et al.. (2016). Potential contribution of the hepcidin-macrophage axis to plaque vulnerability in acute myocardial infarction in human. International Journal of Cardiology. 227. 114–121. 13 indexed citations

11.

Mizukami, Takuya, Yoshitaka Iso, Chisato Sato, et al.. (2016). Priming with erythropoietin enhances cell survival and angiogenic effect of mesenchymal stem cell implantation in rat limb ischemia. Regenerative Therapy. 4. 1–8. 8 indexed citations

12.

Fukagai, Takashi, et al.. (2014). AB21. Association between vascular evaluation and erection hardness score in the patients with ED. Translational Andrology and Urology. 3. 21–21. 1 indexed citations

13.

Fujimoto, Kazumi, Akinori Hayashi, Takuya Watanabe, et al.. (2013). Circulating Levels of Human salusin-β,a Potent Hemodynamic and Atherogenesis Regulator. PLoS ONE. 8(10). e76714–e76714. 37 indexed citations

14.

Iso, Yoshitaka, Takatoshi Sato, Kohei Wakabayashi, et al.. (2011). Effects of erythropoietin on angiogenesis after myocardial infarction in porcine. Heart and Vessels. 27(1). 79–88. 27 indexed citations

15.

Suzuki, Hiroshi, Kiminori Kato, Takuya Ozawa, et al.. (2009). 2 Evaluation of the Prospective Observation of Erythropoietin-Administration for the Treatment of Acute Myocardial Infarction (EPO-AMI)(Late Breaking Clinical Trials II,The 73rd Annual Scientific Meeting of The Japanese Circulation Society). Japanese Circulation Journal-english Edition. 73. 126. 1 indexed citations

16.

Iso, Yoshitaka, Hiroshi Suzuki, Takatoshi Sato, et al.. (2005). Rho-kinase inhibitor suppressed restenosis in porcine coronary balloon angioplasty. International Journal of Cardiology. 106(1). 103–110. 10 indexed citations

17.

Wakabayashi, Kohei, Hiroshi Suzuki, Takatoshi Sato, et al.. (2005). Eplerenone suppresses neointimal formation after coronary stent implantation in swine. International Journal of Cardiology. 107(2). 260–266. 26 indexed citations

18.

Koba, Shinji, Tsutomu Hirano, Yoshitaka Iso, et al.. (2005). Postprandial changes in LDL phenotypes in patients with myocardial infarction. European Journal of Clinical Investigation. 35(3). 171–179. 16 indexed citations

19.

Sato, Takatoshi, Hiroshi Suzuki, Makoto Shoji, et al.. (2003). The Involvement of TNF-α on Myocardial Remodeling after AMI through MMP Expression. Japanese Circulation Journal-english Edition. 67. 401. 2 indexed citations

20.

Iso, Yoshitaka, Hiroshi Suzuki, Makoto Shoji, et al.. (2002). Local delivery of a specific Rho-kinase inhibitor suppressed vascular remodeling after balloon angioplasty in porcine coronary arteries. Japanese Circulation Journal-english Edition. 66(1). 499. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact